US 11060091
Hepatitis B virus (HBV) iRNA compositions and methods of use thereof
granted A61KA61K31/713A61K45/06
Quick answer
US patent 11060091 (Hepatitis B virus (HBV) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 45
- CPC classes
- A61K, A61K31/713, A61K45/06, A61P, A61P1/16